Literature DB >> 11914534

Transoesophageal echocardiography in patients without arterial and major cardiac sources of embolism: difference between stroke subtypes.

P Cerrato1, D Imperiale, L Priano, L Mangiardi, M Morello, A M Marson, F Carrà, G Barberis, B Bergamasco.   

Abstract

We studied the records of 175 consecutive patients referred to our neurologic ward between January 1994 and February 2000 with a diagnosis of ischaemic cerebrovascular disease (ICVD) (stroke or transient ischaemic attack - TIA) who underwent transoesophageal echocardiography (TEE). We excluded patients with large vessel disease, high-risk embolic cardiopathies and other rare causes of stroke. According to clinical and neuroimaging findings, patients were divided into two groups. The lacunar (LAC) group (69/175 (39.4%)) and the nonlacunar (N-LAC) one (106/175 (60.6%)). The control population consisted of 78 consecutive patients, referred to the echocardiography laboratory for TEE without history of ICVD and known heart disorders. Patent foramen ovale (PFO) frequency was significantly higher in case patients than in control subjects (55/175 (31.4%) vs. 13/78 (16.6%); p = 0.02). Among case patients, PFO was more prevalent in the N-LAC group than in the LAC one (43/106 (40.6%) vs. 12/69 (17.4%); p = 0.0005). A large degree of shunt occurred in 53.5% of N-LAC patients and in 16.7% of LAC ones (p = 0.04). Atrial septal aneurysm (ASA) was detected in 12% of case patients and 1.3% of control subjects (p = 0.003) and was more frequent in the N-LAC group than in the LAC one (16 vs. 5.8%; p = 0.05). Mitral prolapse (MP) was present in 6/175 (3.4%) ICVD patients (vs. 1/78 among controls) in most cases associated with myxomatous valve redundancy. Aortic arch atheromas (AA) were detected in 12% of ICVD patients and in 10.2% of controls. The frequency was 9.4% in N-LAC and 15.9 in LAC. No complicated AA (plaque thickness >4 mm, ulcerated atheroma, superimposed thrombus) were detected. After multivariate analysis, PFO (OR = 3.8; 95% CI = 2.7-7.9) and ASA (OR = 8.01; 95% CI = 3.0-16.1) appeared to be independent predictors of ICVD. PFO (OR = 2.24; 95% CI = 1.24-4.92) was also independently associated with N-LAC stroke subtype and its importance was even higher in younger patients. Our study provides further evidence that TEE is a helpful diagnostic tool in stroke patients without arterial and major cardiac sources of embolism. However, its utility differs according to type and localization of the ischaemic lesion being more relevant in patient with N-LAC infarctions. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11914534     DOI: 10.1159/000047772

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  8 in total

1.  Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts.

Authors:  Caroline Jackson; Cathie Sudlow
Journal:  Stroke       Date:  2005-03-10       Impact factor: 7.914

2.  Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study.

Authors:  Domenico Consoli; Maurizio Paciaroni; Marco Aguggia; Maurizio Melis; Giovanni Malferrari; Simone Vidale; Paolo Cerrato; Simona Sacco; Carlo Gandolfo; Paolo Bovi; Carlo Serrati; Massimo Del Sette; Anna Cavallini; Marina Diomedi; Paolo Postorino; Stefano Ricci
Journal:  Neurol Sci       Date:  2014-01-01       Impact factor: 3.307

3.  [Ten key messages regarding embolic stroke of undetermined source and cryptogenic stroke].

Authors:  P Böttger; M Grond; H Lemm; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-11       Impact factor: 0.840

Review 4.  Correlation or causation: untangling the relationship between patent foramen ovale and migraine.

Authors:  Eric Adler; Barry Love; Steve Giovannone; Frank Volpicelli; Martin E Goldman
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

5.  Paroxysmal atrial fibrillation in cryptogenic stroke.

Authors:  Neha S Dangayach; Kevin Kane; Majaz Moonis
Journal:  Ther Clin Risk Manag       Date:  2011-01-28       Impact factor: 2.423

6.  Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.

Authors:  Enfa Zhao; Wenjuan Liu; Yushun Zhang; Gesheng Cheng; Yajuan Du; Lu He; Xingye Wang; Xumei He
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 7.  Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies.

Authors:  Daniel Davis; John Gregson; Peter Willeit; Blossom Stephan; Rustam Al-Shahi Salman; Carol Brayne
Journal:  Neuroepidemiology       Date:  2012-10-11       Impact factor: 3.282

Review 8.  Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review.

Authors:  Ioanna Koutroulou; Georgios Tsivgoulis; Dimitrios Tsalikakis; Dimitris Karacostas; Nikolaos Grigoriadis; Theodoros Karapanayiotides
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.